Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 6/2021

01-12-2021 | Colchicine | Case Report

Mediterranean fever gene-associated enterocolitis in an elderly Japanese woman

Authors: Yasuhiro Shibata, Keisuke Ishigami, Tomoe Kazama, Toshiyuki Kubo, Hiro-o Yamano, Shintaro Sugita, Masaki Murata, Hiroshi Nakase

Published in: Clinical Journal of Gastroenterology | Issue 6/2021

Login to get access

Abstract

An 86-year-old woman was admitted to our hospital with anemia. She had never experienced symptoms of serositis. Colonoscopy revealed colitis with erosions and a friable mucosa. First, she was diagnosed with unclassified inflammatory bowel disease (IBD-U). We suspected familial Mediterranean fever as a differential diagnosis of IBD-U, and MEFV gene analysis showed heterozygosity for Exon2 R202Q. The patient was treated with colchicine 0.5 mg. After 4 months, a follow-up colonoscopy showed remarkable improvement of the mucosal inflammation throughout the entire colon. MEFV gene-associated enterocolitis responding to colchicine may be observed in patients with IBD-U and elucidating the role of MEFV gene mutations in intestinal inflammation is a future challenge.
Literature
1.
go back to reference Migita K, Yuce A, Demir H, et al. Familial Mediterranean fever: overview of pathogenesis, clinical features and management. Dig Dis Sci. 2010;55:3488–94.CrossRef Migita K, Yuce A, Demir H, et al. Familial Mediterranean fever: overview of pathogenesis, clinical features and management. Dig Dis Sci. 2010;55:3488–94.CrossRef
2.
go back to reference Wu B, Xu T, Li Y, et al. Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database Syst Rev. 2018;10:CD010893.PubMed Wu B, Xu T, Li Y, et al. Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database Syst Rev. 2018;10:CD010893.PubMed
3.
go back to reference Migita K, Izumi Y, Jiuchi Y, et al. Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther. 2016;18:175.CrossRef Migita K, Izumi Y, Jiuchi Y, et al. Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther. 2016;18:175.CrossRef
4.
go back to reference de Torre-Minguela C, Mesa Del Castillo P, Pelegrin P. The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 2017;8:43.PubMedPubMedCentral de Torre-Minguela C, Mesa Del Castillo P, Pelegrin P. The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 2017;8:43.PubMedPubMedCentral
5.
go back to reference Charles A, Dinarello MD. Interleukin-1β and the autoinflammatory diseases. New England J Med. 2009;360:2467–70.CrossRef Charles A, Dinarello MD. Interleukin-1β and the autoinflammatory diseases. New England J Med. 2009;360:2467–70.CrossRef
6.
go back to reference Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.CrossRef Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–85.CrossRef
7.
go back to reference Migita K, Uehara R, Nakamura Y, et al. Familial Mediterranean fever in Japan. Medicine (Baltimore). 2012;91:337–43.CrossRef Migita K, Uehara R, Nakamura Y, et al. Familial Mediterranean fever in Japan. Medicine (Baltimore). 2012;91:337–43.CrossRef
8.
go back to reference Ryan JG, Masters SL, Booty MG, et al. Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann Rheum Dis. 2010;69:1383–8.CrossRef Ryan JG, Masters SL, Booty MG, et al. Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann Rheum Dis. 2010;69:1383–8.CrossRef
9.
go back to reference Ben-Chetrit E, Peleg H, Aamar S, et al. The spectrum of MEFV clinical presentations—is it familial Mediterranean fever only? Rheumatology (Oxford). 2009;48:1455–9.CrossRef Ben-Chetrit E, Peleg H, Aamar S, et al. The spectrum of MEFV clinical presentations—is it familial Mediterranean fever only? Rheumatology (Oxford). 2009;48:1455–9.CrossRef
10.
go back to reference Gucenmez OA, Kume T, Makay B, et al. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever. Int J Rheum Dis. 2018;21:1844–8.CrossRef Gucenmez OA, Kume T, Makay B, et al. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever. Int J Rheum Dis. 2018;21:1844–8.CrossRef
11.
go back to reference Sari I, Birlik M, Kasifoglu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol. 2014;1:21–33.CrossRef Sari I, Birlik M, Kasifoglu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol. 2014;1:21–33.CrossRef
12.
go back to reference Higashiyama M, Sugita A, Koganei K, et al. Correction to: management of elderly ulcerative colitis in Japan. J Gastroenterol. 2019;54:936–7.CrossRef Higashiyama M, Sugita A, Koganei K, et al. Correction to: management of elderly ulcerative colitis in Japan. J Gastroenterol. 2019;54:936–7.CrossRef
13.
go back to reference Saito D, Hibi N, Ozaki R, et al. MEFV gene-related enterocolitis account for some cases diagnosed as inflammatory bowel disease unclassified. Digestion. 2020;101:785–93.CrossRef Saito D, Hibi N, Ozaki R, et al. MEFV gene-related enterocolitis account for some cases diagnosed as inflammatory bowel disease unclassified. Digestion. 2020;101:785–93.CrossRef
14.
go back to reference Fujimoto K, Hidaka Y, Koga T, et al. Clinical and genetic analysis of 22 Japanese patients with familial Mediterranean fever: an examination of MEFV and 10 other genes related to autoinflammatory syndromes. Intern Med. 2020;59:1373–8.CrossRef Fujimoto K, Hidaka Y, Koga T, et al. Clinical and genetic analysis of 22 Japanese patients with familial Mediterranean fever: an examination of MEFV and 10 other genes related to autoinflammatory syndromes. Intern Med. 2020;59:1373–8.CrossRef
15.
go back to reference Asakura K, Yanai S, Nakamura S, et al. Familial Mediterranean fever mimicking Crohn disease: a case report. Medicine (Baltimore). 2018;97:9547.CrossRef Asakura K, Yanai S, Nakamura S, et al. Familial Mediterranean fever mimicking Crohn disease: a case report. Medicine (Baltimore). 2018;97:9547.CrossRef
16.
go back to reference Arasawa S, Nakase H, Ozaki Y, et al. Mediterranean mimicker. Lancet. 2012;380:2052.CrossRef Arasawa S, Nakase H, Ozaki Y, et al. Mediterranean mimicker. Lancet. 2012;380:2052.CrossRef
17.
go back to reference Demir A, Akyuz F, Gokturk S, et al. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scand J Gastroenterol. 2014;49:1414–8.CrossRef Demir A, Akyuz F, Gokturk S, et al. Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scand J Gastroenterol. 2014;49:1414–8.CrossRef
18.
go back to reference Esaki M, Kawano S, Matsumoto T. Rare cause of duodenojejunal pseudopolyposis: report of a case of adult-onset familial Mediterranean fever. Dig Endosc. 2017;29:394–5.CrossRef Esaki M, Kawano S, Matsumoto T. Rare cause of duodenojejunal pseudopolyposis: report of a case of adult-onset familial Mediterranean fever. Dig Endosc. 2017;29:394–5.CrossRef
19.
go back to reference Yokoyama Y, Yamakawa T, Ichimiya T, et al. Gastrointestinal involvement in a patient with familial Mediterranean fever mimicking Crohn’s disease: a case report. Clin J Gastroenterol. 2021;14:1103-7.CrossRef Yokoyama Y, Yamakawa T, Ichimiya T, et al. Gastrointestinal involvement in a patient with familial Mediterranean fever mimicking Crohn’s disease: a case report. Clin J Gastroenterol. 2021;14:1103-7.CrossRef
20.
go back to reference Agin M, Tumgor G, Kont A, et al. Endoscopic findings in patients with familial Mediterranean fever and dyspeptic symptoms. Prz Gastroenterol. 2018;13:234–41.PubMedPubMedCentral Agin M, Tumgor G, Kont A, et al. Endoscopic findings in patients with familial Mediterranean fever and dyspeptic symptoms. Prz Gastroenterol. 2018;13:234–41.PubMedPubMedCentral
21.
go back to reference Ozturk MA, Kanbay M, Kasapoglu B, et al. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol. 2011;29:S77-86.PubMed Ozturk MA, Kanbay M, Kasapoglu B, et al. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol. 2011;29:S77-86.PubMed
22.
go back to reference Sargin G, Kose R, Senturk T. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis. Anal Sao Paulo Med J. 2019;137:39–44.CrossRef Sargin G, Kose R, Senturk T. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis. Anal Sao Paulo Med J. 2019;137:39–44.CrossRef
Metadata
Title
Mediterranean fever gene-associated enterocolitis in an elderly Japanese woman
Authors
Yasuhiro Shibata
Keisuke Ishigami
Tomoe Kazama
Toshiyuki Kubo
Hiro-o Yamano
Shintaro Sugita
Masaki Murata
Hiroshi Nakase
Publication date
01-12-2021
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 6/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01497-1

Other articles of this Issue 6/2021

Clinical Journal of Gastroenterology 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.